Trials / Sponsors / CellMed AG, a subsidiary of BTG plc.
CellMed AG, a subsidiary of BTG plc.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Single-centre, Randomised, Double-blind, Placebo-controlled, Four-way Crossover Clinical Study to Investigate Type II Diabetes Mellitus | Phase 1 | 2010-09-01 |
| Completed | Clinical Study to Investigate Safety and Tolerability and Pharmacokinetics of Multiple Ascending Doses of CM3. Healthy | Phase 1 | 2010-07-01 |
| Completed | First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses Healthy | Phase 1 | 2010-02-01 |
| Terminated | GLP-1 CellBeads® for the Treatment of Stroke Patients With Space-occupying Intracerebral Hemorrhage Intracerebral Hemorrhage (ICH) | Phase 1 / Phase 2 | 2008-10-01 |